Alpha DNA Investment Management LLC reduced its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,481 shares of the medical instruments supplier’s stock after selling 535 shares […]
Richard C. Young & CO. LTD. grew its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 7.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,464 shares of the medical instruments supplier’s stock after buying an additional 105 shares during the period. […]
Eli Lilly and Company (NYSE:LLY – Get Free Report) major shareholder Lilly Endowment Inc sold 2,052 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $809.00, for a total transaction of $1,660,068.00. Following the completion of the sale, the insider now owns 98,554,195 […]
Eli Lilly and Company (NYSE:LLY – Get Free Report) major shareholder Lilly Endowment Inc sold 2,052 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $809.00, for a total value of $1,660,068.00. Following the sale, the insider now owns 98,554,195 shares […]
Gold Investment Management Ltd. purchased a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 5,020 shares of the company’s stock, valued at approximately $2,926,000. Eli Lilly and Company accounts for […]